- World marks anniversary of Oct. 7 attack on Israel
- Asian markets track Wall St rally on jobs data
- Cancer, cardiovascular drugs tipped for Nobel as prize week opens
- Tunisia incumbent Saied set to win presidential vote: exit polls
- 'Difficult day': Oct 7 commemorations begin with festival memorial
- Commemorations begin for anniversary of attack on Israel
- Tunisia voting ends as Saied eyes re-election with critics behind bars
- Drowned by hurricane, remote N.Carolina towns now struggle for water
- Two elephants die in flash flooding in northern Thailand
- Tunisia votes with Saied set for re-election
- Too hot by day, Dubai's floodlit beaches are packed at night
- A 'forgotten' valley in storm-hit North Carolina, desperate for help
- Italy targets climate activists in 'anti-Gandhi' demo clampdown
- US trade chief defends tariff hikes when paired with investment
- EU court blocks French ban on vegetable 'steak' labelling
- Meta AI turns pictures into videos with sound
- US dockworkers return to ports after three-day strike
- DR Congo to begin mpox vaccination campaign Saturday in east
- Meta must limit data use for targeted ads: EU court
- Oil extends gains, jobs report lifts Wall Street
- US hiring soars past expectations in sign of resilient market
- As EU targets Chinese cars, European rivals sputter
- Top EU court finds against FIFA in key transfer market ruling
- Oil extends gains, Hong Kong stocks resume rally
- 'A man provides': Ukrainian miners send families away as Russia advances
- EU states greenlight extra tariffs on EVs from China
- Hong Kong stocks resume rally, oil dips after Middle East-fuelled surge
- Crude stable after Israel-Iran surge, Hong Kong stocks resume gains
- Hera spacecraft to probe asteroid deflected by defence test
- US dockworkers to head back to work after tentative deal
- After Helene's destruction, North Carolina starts to rebuild
- Dockers end three-day strike at Montreal port
- What next for OpenAI after $157 billion bonanza?
- Israel-Hamas war causes 86-percent dive in Gaza GDP: IMF
- Milan's Morata moves house after Inter-fan town mayor 'violates' privacy
- 'Devastating' storm hits Augusta National but Masters will go on
- Relief in Brazil, Asia over delay to EU deforestation rules
- Oil prices jump, stocks fall on Middle East tensions
- Biden says 'discussing' possible Israeli strikes on Iran oil facilities
- Oil prices rise, stocks fall on Middle East tensions
- Oil rallies, stocks mostly retreat on Middle East tensions
- Phasing out teen smoking could save 1.2 mn lives: study
- 'Welcome relief': Asia producers hail EU deforestation law delay
- Japan PM slated to announce plans for 'happiness index'
- Turkish inflation falls less than expected in September at 49.4%
- Easing inflation lifts profit at UK supermarket Tesco
- Skiing calls on UN climate science to combat melting future
- China wine industry looks to breed climate resilience
- Tokyo rallies on weak yen, Hong Kong drops after surge
- Dutch airline KLM unveils 'firm' cost-cutting measures
US authorities relax regulations on prescription opioids
US health officials issued new recommendations Thursday to relax restrictions for doctors prescribing opioids for pain, despite the risk of addiction.
The Centers for Disease Control (CDC) revised principles issued in 2016 in an attempt to curb the opioid overdose epidemic in the United States.
Unlike the previous document, the new guide refrains from setting thresholds in terms of dosage or prescription duration.
These had led doctors to suddenly cut or drastically reduce patients' doses. States and insurance companies were also inspired to set their own limits.
Chronic pain patients had complained that they no longer had access to the drugs that would allow them to lead a normal life, and had warned of the increased risk of suicide in their ranks.
The new recommendations, compiled in a 200-page report, seek a balance. One in five Americans suffers from chronic pain and "opioids can be essential medications for the management of pain, however, they carry considerable potential risk," the authors of the document wrote.
The guidelines are not "a replacement for clinical judgment or individualized, person-centered care" or "intended to be applied as inflexible standards of care," the report says.
But it recommends caution, warning that opioids should be considered only after other pain treatments have failed, and at each step, physicians should discuss the issue with their patients.
If they decide to use opioids, they should first prescribe the lowest effective dose and then closely monitor the effects of the treatment.
If problems arise, physicians should also avoid abruptly terminating opioid prescriptions and should ensure appropriate care for those with complications.
As a precautionary measure, the agency recommends that people using opioids over a prolonged period be offered Naloxone, an antidote that can save someone who is overdosing, said Christopher Jones, a senior CDC official, at a press briefing.
Opioid prescriptions increased fourfold between 1999 and 2010 in the United States. Although the trend has reversed since 2016, they have created addictions and driven some patients to drugs like heroin and fentanyl.
Last year, the US had a record 107,000 overdose deaths, more than 70 percent of which were from illegal synthetic opioids.
D.Avraham--CPN